Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Myriad Genetics (MYGN) Shares Outstanding (Diluted Average): 2009-2025

Historic Shares Outstanding (Diluted Average) for Myriad Genetics (MYGN) over the last 9 years, with Sep 2025 value amounting to $93.1 million.

  • Myriad Genetics' Shares Outstanding (Diluted Average) rose 2.42% to $93.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $93.1 million, marking a year-over-year increase of 2.42%. This contributed to the annual value of $90.6 million for FY2024, which is 9.42% up from last year.
  • As of Q3 2025, Myriad Genetics' Shares Outstanding (Diluted Average) stood at $93.1 million, which was up 0.65% from $92.5 million recorded in Q2 2025.
  • Myriad Genetics' 5-year Shares Outstanding (Diluted Average) high stood at $93.1 million for Q3 2025, and its period low was $76.0 million during Q1 2021.
  • In the last 3 years, Myriad Genetics' Shares Outstanding (Diluted Average) had a median value of $90.6 million in 2024 and averaged $87.9 million.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first decreased by 0.98% in 2022, then increased by 10.99% in 2024.
  • Over the past 5 years, Myriad Genetics' Shares Outstanding (Diluted Average) (Quarterly) stood at $78.0 million in 2021, then grew by 3.33% to $80.6 million in 2022, then grew by 2.73% to $82.8 million in 2023, then increased by 9.42% to $90.6 million in 2024, then grew by 2.42% to $93.1 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $93.1 million in Q3 2025, compared to $92.5 million in Q2 2025 and $91.4 million in Q1 2025.